Skip Navigation


Glycobiology Advance Access originally published online on October 16, 2006
Glycobiology 2007 17(2):185-196; doi:10.1093/glycob/cwl059
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/2/185    most recent
cwl059v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Garcia, J.
Right arrow Articles by Borsig, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia, J.
Right arrow Articles by Borsig, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

P-selectin mediates metastatic progression through binding to sulfatides on tumor cells

Josep Garcia3,4, Nico Callewaert2,5 and Lubor Borsig1,3,4

3 Center for Integrative Human Physiology
4 Institute of Physiology, University of Zürich, 8057 Zürich, Switzerland
5 GlycoInit ETH, Swiss Federal Institute of Technology Zurich, Wolfgang Paulistrasse 10, CH-8093 Zürich, Switzerland


1 To whom correspondence should be addressed; Tel: +41 44 635 5134; Fax: +41 44 635 6814; e-mail: lborsig{at}access.unizh.ch

Received on June 21, 2006; revised on October 4, 2006; accepted on October 6, 2006

Hematogenous carcinoma metastasis is associated with tumor cell emboli formation, which is now known to be facilitated by selectins. P-selectin-mediated interactions of platelets with cancer cells are based mostly on mucin- and glycosaminoglycan-type selectin ligands. We previously showed that mouse colon carcinoma cells (MC-38) carry P-selectin ligands of nonmucin origin, which were not identified. Here we show that P-selectin ligands recognized on MC-38 cells are sulfated glycolipids, thereby facilitating experimental metastasis in a syngeneic mouse model. Metabolic inhibition of sulfation by incubation of cells with sodium chlorate almost completely abrogated P-selectin binding. Metabolic labeling of MC-38 cells with 35S sulfate revealed only a single band as detected by high-performance thin layer chromatography analysis of a total lipid extract. Matrix-assisted laser desorption/ionization tandem time-of-flight/time-of-flight analysis (MALDI-TOF-TOF) analysis of the purified sulfate-containing lipid fraction identified the selectin ligand to be a sulfated galactosylceramide SM4 (HSO3-3Galß-1Cer). Modulation of glycolipid biosynthesis in MC-38 cells altered P-selectin binding, thereby confirming sulfoglycolipids to be major P-selectin ligands. In addition, P-selectin was also found to recognize lactosylceramide sulfate SM3 (HSO3-3Galß-4Glcß-1Cer) and gangliotriaosylceramide sulfate SM2 [GalNAcß-4(HSO3-3)Galß-4Glcß-1Cer] in human hepatoma cells. Finally, the enzymatic removal of sulfation from the cell surface of MC-38 cells resulted in decreased P-selectin binding and led to attenuation of metastasis. Thus, SM4 sulfatide serves as a native ligand for P-selectin contributing to cell–cell interactions and to facilitation of metastasis.

Key words: carbohydrate sulfation / glycolipids / MALDI-TOF / metastasis / selectin


2 Present address: Unit for Molecular Glycobiology, Department for Molecular Biomedical Research, Ghent University and VIB, Technologiepark 927, B-9052 Ghent-Zwijnaarde, Belgium

None declared.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.